Objectives.This study determined the effect of sotalol on atrial function after electrical cardioversion of atrial fibrillation.Background.After electrical cardioversion of atrial fibrillation, the Doppler mitral A wave is often diminished, representing impaired atrial contractile function. Sotalol is an effective atrial antiarrhythmic drug with class III and beta-adrenergic blocking properties. Although the negative inotropic effect of sotalol on the ventricle is minimal in patients with normal ventricular function, it may manifest negative inotropy when ventricular function is impaired. We postulated that after cardioversion, when intrinsic atrial function is impaired, sotalol may have an adverse effect on the atrium.Methods.Thirty-seven ...
We used 24-hour ambulatory ECG monitoring (AEM) to determine sotalol's circadian heart rate (HR) eff...
AbstractObjectives. This study examines the effects of sotalol on the signal-averaged electrocardiog...
Sotalol is a beta-adrenergic blocking drug with the additional property of lengthening the cardiac a...
AbstractObjectivesWe sought to determine the electrophysiologic actions of sotalol in the remodeled ...
AbstractOBJECTIVESWe sought to study the rate related effects of sotalol on myocardial contractility...
OBJECTIVES:This study was undertaken to assess the effects of sotalol on the transthoracic cardiover...
Sotalol is a beta-adrenergic blocking agent that prolongs the duration of the cardiac action potenti...
OBJECTIVES: We sought to determine the electrophysiologic actions of sotalol in the remodeled atrium...
AbstractObjectives. This study investigated the hemodynamic effects of oral sotalol during both sinu...
BackgroundTransvenous atrial defibrillation (IADF) is a recently developing technique for converting...
Although discovered more than two decades ago, the clinical applications of sotalol are still a matt...
ObjectivesThis study sought to compare the influence of changes in systolic interval on the negative...
Sotalol is a unique beta-adrenergic blocking agent with additional actions characteristic of Vaughn-...
OBJECTIVES: This study investigated the hemodynamic effects of oral sotalol during both sinus rhythm...
AbstractSixty-five patients with symptomatic, drug-refractory, sustained ventricular tachycardia or ...
We used 24-hour ambulatory ECG monitoring (AEM) to determine sotalol's circadian heart rate (HR) eff...
AbstractObjectives. This study examines the effects of sotalol on the signal-averaged electrocardiog...
Sotalol is a beta-adrenergic blocking drug with the additional property of lengthening the cardiac a...
AbstractObjectivesWe sought to determine the electrophysiologic actions of sotalol in the remodeled ...
AbstractOBJECTIVESWe sought to study the rate related effects of sotalol on myocardial contractility...
OBJECTIVES:This study was undertaken to assess the effects of sotalol on the transthoracic cardiover...
Sotalol is a beta-adrenergic blocking agent that prolongs the duration of the cardiac action potenti...
OBJECTIVES: We sought to determine the electrophysiologic actions of sotalol in the remodeled atrium...
AbstractObjectives. This study investigated the hemodynamic effects of oral sotalol during both sinu...
BackgroundTransvenous atrial defibrillation (IADF) is a recently developing technique for converting...
Although discovered more than two decades ago, the clinical applications of sotalol are still a matt...
ObjectivesThis study sought to compare the influence of changes in systolic interval on the negative...
Sotalol is a unique beta-adrenergic blocking agent with additional actions characteristic of Vaughn-...
OBJECTIVES: This study investigated the hemodynamic effects of oral sotalol during both sinus rhythm...
AbstractSixty-five patients with symptomatic, drug-refractory, sustained ventricular tachycardia or ...
We used 24-hour ambulatory ECG monitoring (AEM) to determine sotalol's circadian heart rate (HR) eff...
AbstractObjectives. This study examines the effects of sotalol on the signal-averaged electrocardiog...
Sotalol is a beta-adrenergic blocking drug with the additional property of lengthening the cardiac a...